Pulmonary alveolar microlithiasis: an overview of clinical and pathological features together with possible therapies

Therapy of disseminated malignant melano

Therapy of disseminated malignant melanoma with recombinant α 2b-interferon and piroxicam: Clinical results with a report of an unusual response-associated feature (Vitiligo) and unusual toxicity (diffuse pulmonary interstitial fibrosis)

✍ Harris, Jules ;Bines, Steven ;Das Gupta, Tapas 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

## Abstract Fifteen patients with disseminated malignant melanoma were treated with recombinant a 2b‐interferon (20 mU/m^2^ intravenously 5 days per week for 4 weeks and then 10 mU/m^2^ subcutaneously tiw) and piroxicam (10 mg a day orally for 10 days prior to beginning interferon and daily thereaf